Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Large down gaps, monthly chart 2019 July & August

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Dec 21, 2021 9:54am

648 Views

Post# 34250052

RE:RE:RE:Large down gaps, monthly chart 2019 July & August

At the closing of the phase one study buyers were looking for the next buisness devlopment and it was a long ways out. The price fall began in March. Other investers soon realized how far out the next signifigant steps would be taken for Phase 2 Pivitol. And the market forces propelled.

The market forces are again propelling in the opposite.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project